Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, Tae-Wook, Carruth, Lucy, Finzi, Diana, Shen, Xuefei, DiGiuseppe, Joseph A., Taylor, Harry, Hermankova, Monika, Chadwick, Karen, Margolick, Joseph, Quinn, Thomas C., Kuo, Yen-Hong, Brookmeyer, Ronald, Zeiger, Martha A., Barditch-Crovo, Patricia, Siliciano, Robert F.·1997·Nature

DOI 10.1038/387183a0

Cited by (1,000)

Items 501–600 of 1,000

Human Immunodeficiency Virus (HIV) Latency: The Major Hurdle in HIV Eradication
Mudit Tyagi, Michael Bukrinsky · 2012 · Molecular Medicine
Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir
Zheng Wang, Francesco Roberto Simonetti, Robert F. Siliciano, Gregory M. Laird · 2018 · Retrovirology
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
Rémi Fromentin, Nicolas Chomont · 2020 · Seminars in Immunology
Rapid CD4+ T-cell turnover in HIV-1 infection: A paradigm revisited
Katja C. Wolthers, Hanneke Schuitemaker, Frank F. Miedema · 1998 · Immunology Today
A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication
Belgin Sever, Masami Otsuka, Mikako Fujita, Halil I. Ciftci · 2024 · International Journal of Molecular Sciences
HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
Tessa C. Chou, Nishad S. Maggirwar, Matthew D. Marsden · 2024 · Viruses
Epigenetic Heterogeneity in HIV-1 Latency Establishment
Yuka Matsuda, Mie Kobayashi‐Ishihara, Dai Fujikawa, Takaomi Ishida, Toshiki Watanabe, Makoto Yamagishi · 2015 · Scientific Reports
Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1
Thomas W. North, Koen K. A. Van Rompay, Joanne Higgins, Timothy B. Matthews, Debra A. Wadford, Niels C. Pedersen, Raymond F. Schinazi · 2005 · Journal of Virology
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes
Lætitia Redel, Valentin Le Douce, Thomas Cherrier, Céline Marban, Andrea Janossy, Dominique Aunis, Carine M. Van Lint, Olivier Rohr, Christian Schwartz · 2009 · Journal of Leukocyte Biology
Eradication of HIV: current challenges and new directions
Matthew D. Marsden, Jerome A. Zack · 2008 · Journal of Antimicrobial Chemotherapy
Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults
Mohammad-Ali Jenabian, Cecilia Theresa Costiniuk, Vikram Mehraj, Feras M. Ghazawi, Rémi Fromentin, Joëlle Brousseau, Pierre Brassard, Maud Bélanger, Petronela Ancuța, Reina Bendayan et al. · 2016 · AIDS
T Cell Dynamics in HIV-1 Infection
Dawn R. Clark, Rob J. de Boer, Katja C. Wolthers, Frank F. Miedema · 1999 · Advances in immunology
Low‐level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T‐cells
Gautam Kumar Sahu, David P. Paar, Simon D. W. Frost, Melissa M. Smith, Scott C. Weaver, Miles W. Cloyd · 2008 · Journal of Medical Virology
Modelling HIV immune response and validation with clinical data
Harvey Thomas Banks, Marie Davidian, Shuhua Hu, Grace Martinelli Kepler, Eric S. Rosenberg · 2008 · Journal of Biological Dynamics
In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection
Perry Tsai, Guoxin Wu, Caroline Baker, William O. Thayer, Rae Ann Spagnuolo, Rosa I. Sánchez, Stephanie E. Barrett, Bonnie J. Howell, David M. Margolis, Daria J. Hazuda et al. · 2016 · Retrovirology
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies
Justin C. McArthur, Tory P. Johnson · 2020 · Current Opinion in Neurology
Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy
Michele Di Mascio, Ruy Miguel Ribeiro, Martin H. Markowitz, David D. Ho, Alan S. Perelson · 2003 · Mathematical Biosciences
Role of F c‐mediated antibody function in protective immunity against HIV ‐1
George K. Lewis · 2013 · Immunology
HIV-1 eradication strategies
Janet D'Angelo Siliciano, Robert F. Siliciano · 2013 · Current Opinion in HIV and AIDS
Model of HIV-1 Disease Progression Based on Virus-Induced Lymph Node Homing and Homing-Induced Apoptosis of CD4+ Lymphocytes
Denise E. Kirschner, Glenn F. Webb, Miles W. Cloyd · 2000 · JAIDS Journal of Acquired Immune Deficiency Syndromes
In the Garden of Branching Processes
Karin S. Dorman, Janet S. Sinsheimer, Kenneth L. Lange · 2004 · SIAM Review
Testicular germ cells of HIV-seropositive asymptomatic men are infected by the virus
Barbara Muciaccia, Antonio Filippini, Elio Ziparo, Fabrizio Colelli, Carlo D. Baroni, Mario Stefanini · 1998 · Journal of Reproductive Immunology
Uncoating of HIV-1 requires cellular activation
Prasert Auewarakul, Pathawut Wacharapornin, Sirawat Srichatrapimuk, Somchai Chutipongtanate, Pilaipan Puthavathana · 2005 · Virology
Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART
Choo Beng Chew, Simon J. Potter, Bin Wang, Yuan Min Wang, Chanh Op Shaw, Dominic E. Dwyer, Nitin K. Saksena · 2004 · Journal of Clinical Virology
Targeted Derepression of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat by Pyrrole-Imidazole Polyamides
Jason J. Coull, Guocheng He, Christian Melander, Victor C. Rucker, Peter B. Dervan, David M. Margolis · 2002 · Journal of Virology
Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma
Anthony Richard Cillo, Amrita Y. Krishnan, Ronald T. Mitsuyasu, Deborah K. McMahon, Shirley Li, John J. Rossi, John A. Zaia, John W. Mellors · 2013 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Genome-wide CRISPR knockout screen identifies ZNF304 as a silencer of HIV transcription that promotes viral latency
Simona Krasnopolsky, Alona Kuzmina, Ran Taube · 2020 · PLoS Pathogens
Lost in Transcription: Molecular Mechanisms that Control HIV Latency
Ran Taube, Boris Matija Peterlin · 2013 · Viruses
A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system
Janice E. Clements, Lúcio Gama, David R. M. Graham, Joseph L. Mankowski, M. Christine Zink · 2010 · Current Opinion in HIV and AIDS
Protocol for Nearly Full-Length Sequencing of HIV-1 RNA from Plasma
Yuka Nadai, Lindsay M. Eyzaguirre, Niel T. Constantine, Anne McDonnell Sill, Farley R. Cleghorn, William A. Blattner, Jean K. Carr · 2008 · PLoS ONE
Early Archiving and Predominance of Nonnucleoside Reverse Transcriptase Inhibitor–Resistant HIV‐1 among Recently Infected Infants Born in the United States
Deborah Persaud, Paul E Palumbo, Carrie Ziemniak, Jie Chen, Stuart C. Ray, Michael Hughes, Peter L. Havens, Murli Udharam Purswani, Aditya H. Gaur, ELLEN GOULD CHADWICK · 2007 · The Journal of Infectious Diseases
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
Line K. Vibholm, Julio C. C. Lorenzi, Joy A. Pai, Yehuda Z. Cohen, Thiago Y. Oliveira, John P. Barton, Marco Garcia Noceda, Ching-Lan Lu, Yuria Ablanedo‐Terrazas, Perla M. Del Río Estrada et al. · 2019 · Journal of Virology
The multifaceted nature of HIV latency
Caroline Dufour, Pierre Gantner, Rémi Fromentin, Nicolas Chomont · 2021 · Journal of Clinical Investigation
Presence and cellular distribution of HIV in the testes of seropositive subjects: an evaluation by in situ PCR hybridization
Barbara Muciaccia, Stefania Uccini, Antonio Filippini, Elio Ziparo, François Paraire, Carlo Davide Baroni, Mario Stefanini · 1998 · The FASEB Journal
Immune privilege and HIV‐1 persistence in the CNS
Yuri Persidsky, Larisa Y. Poluektova · 2006 · Immunological Reviews
Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity
Steven A. Yukl, Satish K. Pillai, Peilin Li, Karen Chang, William Pasutti, Chris Ahlgren, Diane V. Havlir, Matthew C. Strain, Huldrych F. Günthard, Douglas D. Richman et al. · 2009 · Virology
Challenges and strategies for the eradication of the HIV reservoir
Jason T. Kimata, Andrew P. Rice, Jin Wang · 2016 · Current Opinion in Immunology
Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART
Caroline Dufour, María Julia Ruiz, Amélie Pagliuzza, Corentin Richard, Aniqa Shahid, Rémi Fromentin, Rosalie Ponte, Amélie Cattin, Tomas Raul Wiche Salinas, Syim Salahuddin et al. · 2023 · Cell Reports
Viral Integration and Consequences on Host Gene Expression
Sébastien Desfarges, Angela Ciuffi · 2012 · Springer eBooks
Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus
Laura J. Martins, Pawel Bonczkowski, Adam M. Spivak, Ward De Spiegelaere, Camille L. Novis, Ana Beatriz DePaula-Silva, Eva Malatinková, Wim Trypsteen, Alberto Bosque, Linos Vanderkerckhove et al. · 2015 · AIDS Research and Human Retroviruses
Long-Term Multiple-Dose Pharmacokinetics of Human Monoclonal Antibodies (MAbs) against Human Immunodeficiency Virus Type 1 Envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)
Béda Joos, Alexandra Trkola, Herbert Kuster, Leonardo Aceto, Marek Fischer, Gabriela M. Stiegler, Christine Armbruster, Brigitta A. Vcelar, Hermann W. D. Katinger, Huldrych F. Günthard · 2006 · Antimicrobial Agents and Chemotherapy
Antiretroviral Therapy in Resource-Limited Settings
Anthony Amoroso, Charles E. L. B. Davis, Robert Redfield · 2005 · Kluwer Academic Publishers eBooks
Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
Neil M. Ferguson, Frank de Wolf, Azra C. Ghani, Christophe Fraser, Christl Ann Donnelly, Peter Reiss, Joep M. A. Lange, Sven A. Danner, Geoff P. Garnett, Jaap Goudsmit et al. · 1999 · Proceedings of the National Academy of Sciences
HIV Reservoirs and Strategies for Eradication
Miranda Z. Smith, Fiona Wightman, Sharon R. Lewin · 2012 · Current HIV/AIDS Reports
Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants
Priyanka Uprety, ELLEN GOULD CHADWICK, Kaitlin Rainwater‐Lovett, Carrie Ziemniak, Katherine Luzuriaga, Edmund V. Capparelli, Gayane Yenokyan, Deborah Persaud · 2015 · Clinical Infectious Diseases
Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique
Amy E. Baxter, Julia Niessl, Rémi Fromentin, Jonathan Richard, Filippos Porichis, Marta Massanella, Nathalie Brassard, Nirmin Alsahafi, Jean‐Pierre Routy, Andrés Finzi et al. · 2017 · Nature Protocols
Human Immunodeficiency Virus Vaccine Trials
Robert J. O’Connell, J. H. Kim, Lawrence Corey, N. L. Michael · 2012 · Cold Spring Harbor Perspectives in Medicine
Mechanisms of enhanced HIV spread through T‐cell virological synapses
Benjamin M. Dale, Raymond A. Alvarez, Benjamin K. Chen · 2012 · Immunological Reviews
Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents
David M. Margolis, Nancie M. Archin · 2016 · The Journal of Infectious Diseases
Surfactant Proteins A and D: Trimerized Innate Immunity Proteins with an Affinity for Viral Fusion Proteins
Alastair Watson, Maximillian J. S. Phipps, Howard William Clark, Chris‐Kriton Skylaris, Jens Madsen · 2018 · Journal of Innate Immunity
Slow Human Immunodeficiency Virus Type 1 Evolution in Viral Reservoirs in Infants Treated with Effective Antiretroviral Therapy
Deborah Persaud, Stuart C. Ray, Joleen Kajdas, Aima A. Ahonkhai, George Kelly Siberry, Kimberly C. Ferguson, Carrie Ziemniak, Thomas C. Quinn, Joseph P. Casazza, Steven L. Zeichner et al. · 2007 · AIDS Research and Human Retroviruses
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
Maria José Buzón, Francisco M. Codoñer, Simon D. W. Frost, Christian Pou, Maria Carmen Puertas, Marta Massanella, Judith Dalmau, Josep Maria Llibre, Mario Stevenson, Julià Blanco et al. · 2011 · PLoS Pathogens
Design and potential of non-integrating lentiviral vectors
Shaw, Aaron, Cornetta, Kenneth · 2014 · Biomedicines
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer
Rebecca Rose, Susanna L. Lamers, David J. Nolan, Ekaterina Maidji, Nuno Rodrigues Faria, Oliver G. Pybus, James Jarad Dollar, Samuel A. Maruniak, Andrew C. McAvoy, Marco Salemi et al. · 2016 · Journal of Virology
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.
Robert W. Shafer, Kathryn Margaret Dupnik, Mark A. Winters, Susan H. Eshleman · 2001 · PubMed
A simple relationship between viral load and survival time in HIV-1 infection
Ramy Arnaout, Alun L. Lloyd, Thomas R. OʼBrien, James J. Goedert, John M. Leonard, Martin A. Nowak · 1999 · Proceedings of the National Academy of Sciences
Prospects of HIV‐1 entry inhibitors as novel therapeutics
Theodore C. Pierson, Robert W. Doms, Stefan Pöhlmann · 2004 · Reviews in Medical Virology
Predicting differential responses to structured treatment interruptions during HAART
Seema H. Bajaria · 2004 · Bulletin of Mathematical Biology
Cell line-dependent variability in HIV activation employing DNMT inhibitors
Guerau Fernández, Steven L. Zeichner · 2010 · Virology Journal
Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression
Thomas D. Zaikos, Mark M. Painter, Nadia T. Sebastian, Valeri H. Terry, Kathleen L. Collins · 2018 · Journal of Virology
Dynamics of Naive and Memory CD4+ T Lymphocytes in HIV-1 Disease Progression
Seema H. Bajaria, Glenn F. Webb, Miles W. Cloyd, Denise E. Kirschner · 2002 · JAIDS Journal of Acquired Immune Deficiency Syndromes
Upregulation of Fas Ligand by Simian Immunodeficiency Virus—A nef-arious Mechanism of Immune Evasion?
R. Paul Johnson · 1997 · The Journal of Experimental Medicine
TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia
Gregory Q. Del Prete, W. Gregory Alvord, Yuan Li, Claire Deléage, Mukta Nag, Kelli A. Oswald, James Andrew Thomas, Cathi Pyle, William J. Bosche, Vicky J. Coalter et al. · 2019 · JCI Insight
Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs
Christophe Fraser, Neil M. Ferguson, Azra C. Ghani, Jan M. Prins, Joep M. A. Lange, Jaap Goudsmit, Roy Malcolm Anderson, Frank de Wolf · 2000 · AIDS
LFA-1 Is a Key Determinant for Preferential Infection of Memory CD4+T Cells by Human Immunodeficiency Virus Type 1
Mélanie R. Tardif, Michel J. Tremblay · 2005 · Journal of Virology
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections
Giuseppe Nunnari, Miguel A. Otero, Geethanjali Dornadula, Michelle Vanella, Hui Zhang, Ian Frank, Roger J. Pomerantz · 2002 · AIDS
Anti-AIDS Agents 90. Novel C-28 Modified Bevirimat Analogues as Potent HIV Maturation Inhibitors
Keduo Qian, Ibrahim D. Bori, Chin‐Ho Chen, Li Huang, Kuo‐Hsiung Lee · 2012 · Journal of Medicinal Chemistry
Cell-Associated Viral Burden Provides Evidence of Ongoing Viral Replication in Aviremic HIV-2-Infected Patients
Rui Silva Soares, Rita Tendeiro Rego, Russell B. Foxall, António P. Baptista, Rita Cavaleiro, Perpétua Gómes, Ricardo Jorge Camacho, Emília Valadas, Manuela Doroana, Margarida B. Lucas et al. · 2010 · Journal of Virology
Neutral Theory and Rapidly Evolving Viral Pathogens
Simon D. W. Frost, Brittany Rife Magalis, Sergei L. Kosakovsky Pond · 2018 · Molecular Biology and Evolution
Gag-Positive Reservoir Cells Are Susceptible to HIV-Specific Cytotoxic T Lymphocyte Mediated Clearance In Vitro and Can Be Detected In Vivo
Erin H. Graf, Matthew J. Pace, Bennett A. Peterson, Lindsay J. Lynch, Steve B. Chukwulebe, Angela M. Mexas, Farida Shaheen, Jeffrey N. Martin, Steven G. Deeks, Mark Connors et al. · 2013 · PLoS ONE
A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence
Michelle Kim, Nina N. Hosmane, C. Korin Bullen, Adam A. Capoferri, Hung‐Chih Yang, Janet D'Angelo Siliciano, Robert F. Siliciano · 2014 · Nature Protocols
Achieving a cure for HIV infection: do we have reasons to be optimistic?
Valentin Le Douce, Andrea Janossy, Houda Hallay, Sultan Ali, Raphaël Riclet, Olivier Rohr, Christian Schwartz · 2012 · Journal of Antimicrobial Chemotherapy
Expression of Latent HAART-Persistent HIV Type 1 Induced by Novel Cellular Activating Agents
Joseph Kulkosky, Julie Sullivan, Yan Xu, Emily Souder, Dean H. Hamer, Roger J. Pomerantz · 2004 · AIDS Research and Human Retroviruses
Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals
Riddhima Banga, Francesco A. Procopio, Alessandra Ruggiero, Alessandra Noto, Khalid Ohmiti, Matthias L. Cavassini, Jean-Marc Corpataux, William A. Paxton, Georgios Pollakis, Matthieu Perreau · 2018 · Frontiers in Immunology
Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal
Christine Marian, Mateusz Stoszko, Lili Wang, Matthew W. Leighty, Elisa De Crignis, Chad A. Maschinot, Jovylyn Gatchalian, Benjamin C. Carter, Basudev Chowdhury, Diana C. Hargreaves et al. · 2018 · Cell chemical biology
The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like
Gilles Darcis, Ben Berkhout, Alexander O. Pasternak · 2019 · Frontiers in Immunology
Combination Immune Checkpoint Blockade to Reverse HIV Latency
Renée Marije van der Sluis, Nitasha Kumar, Rachel D. Pascoe, Jennifer M. Zerbato, Vanessa A. Evans, Ashanti Dantanarayana, Jenny L. Anderson, Rafick‐Pierre Sékaly, Rémi Fromentin, Nicolas Chomont et al. · 2020 · The Journal of Immunology
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
Lucas E. Hermans, Sergio Carmona, Monique Nijhuis, Hugo A. Tempelman, Douglas D. Richman, Michelle A. Moorhouse, Diederick E. Grobbee, François Venter, Annemarie M. J. Wensing · 2020 · PLoS Medicine
Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men
Thomas M. Lampinen, Cathy W. Critchlow, Jane M. Kuypers, Carla S. Hurt, Paul J. Nelson, Stephen E. Hawes, Robert W. Coombs, King K. Holmes, Nancy B. Kiviat · 2000 · AIDS
Polyamides Reveal a Role for Repression in Latency within Resting T Cells of HIV‐Infected Donors
Loyda Ylisastigui, Jason J. Coull, Victor C. Rucker, Christian Melander, Ronald J. Bosch, Scott J. Brodie, Lawrence Corey, Donald L. Sodora, Peter B. Dervan, David M. Margolis · 2004 · The Journal of Infectious Diseases
Enfermedades Infecciosas y Microbiología Clínica
Rafael Bastos Delgado · 2016
Mechanisms of HIV Transcriptional Regulation and Their Contribution to Latency
Gillian M. Schiralli Lester, Andrew J. Henderson · 2012 · Molecular Biology International
Practical Identifiability of HIV Dynamics Models
Jérémie Guedj, Rodolphe Thiébaut, Daniel Commenges · 2007 · Bulletin of Mathematical Biology
Low-level HIV-1 replication and the dynamics of the resting CD4+T cell reservoir for HIV-1 in the setting of HAART
Ahmad R. Sedaghat, Robert F. Siliciano, Claus O. Wilke · 2008 · BMC Infectious Diseases
Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach
Viktor Müller, Athanasius F. M. Marée, Rob J. de Boer · 2001 · Proceedings of the Royal Society B Biological Sciences
The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets
Jim A. Turpin · 2003 · Expert Review of Anti-infective Therapy
Early physiological abnormalities after simian immunodeficiency virus infection
Thomas F. W. Horn, Salvador Huitrón‐Reséndiz, Michael R. Weed, Steven J. Henriksen, Howard S. Fox · 1998 · Proceedings of the National Academy of Sciences
British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy
2003 · HIV Medicine
Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients
Anni Assing Winckelmann, Lærke V. Munk-Petersen, Thomas A. Rasmussen, Jesper Melchjorsen, Thomas Johannesson Hjelholt, David C. Montefiori, Lars Jørgen Østergaard, Ole Schmeltz Søgaard, Martin Tolstrup · 2013 · PLoS ONE
CD27− B-Cells Produce Class Switched and Somatically Hyper-Mutated Antibodies during Chronic HIV-1 Infection
Alberto Cagigi, Likun Du, Linh Vu Phuong Dang, Sven Grützmeier, Ann Atlas, Francesca Chiodi, Qiang Pan‐Hammarström, Anna Nilsson · 2009 · PLoS ONE
Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages
Hocine Slimani, Nathalie Charnaux, Elisabeth Mbemba, Line Saffar, Roger Vassy, Claudio Vita, Liliane Gattegno · 2003 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Transcriptional Suppression of In Vitro-Integrated Human Immunodeficiency Virus Type 1 Does Not Correlate with Proviral DNA Methylation
Marjorie Pion, Albert Jordan, Angélique Biancotto, Franck Dequiedt, Françoise Gondois‐Rey, Sophie Rondeau, Robert Vigne, Jiřı́ Hejnar, Eric M. Verdin, Ivan Hirsch · 2003 · Journal of Virology
HIV‐1–Specific Cytotoxic T Lymphocytes and Breast Milk HIV‐1 Transmission
Grace C. John-Stewart, Dorothy Mbori‐Ngacha, Barbara Lohman Payne, Carey Farquhar, Barbra A. Richardson, Sandra Emery, Phelgona Apondi Otieno, Elizabeth Maleche Obimbo, Tao Dong, Jennifer A. Slyker et al. · 2009 · The Journal of Infectious Diseases
Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection
Guido Ferrari, Barton F. Haynes, Scott Koenig, Jeffrey L. Nordstrom, David M. Margolis, Georgia D. Tomaras · 2016 · Nature Reviews Drug Discovery
High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay
Robert W. Yucha, Kristen S. Hobbs, Emily Hanhauser, Louise E. Hogan, Wildaliz Nieves, Mehmet Ozgün Ozen, Fatih İnci, Vanessa A. York, Erica A. Gibson, Cassandra Thanh et al. · 2017 · EBioMedicine
Identification of a CCR5-Expressing T Cell Subset That Is Resistant to R5-Tropic HIV Infection
Kyra A Oswald-Richter, Stacy M. Grill, Mindy Leelawong, Michelle Tseng, Spyros A. Kalams, Todd Hulgan, David W. Haas, Derya Unutmaz · 2007 · PLoS Pathogens
HIV-1 rebound after anti-retroviral therapy
David D. Ho, Linqi Zhang · 2000 · Nature Medicine
Simian Immunodeficiency Virus: A Model for NeuroAIDS
Howard S. Fox, Lisa H. Gold, Steven J. Henriksen, Floyd E. Bloom · 1997 · Neurobiology of Disease
Immune Control of HIV
Muthukumar Balasubramaniam, Jui Pandhare, Chandravanu Dash · 2019 · JoLS Journal of Life Sciences
Early and Prolonged Antiretroviral Therapy Is Associated with an HIV-1-Specific T-Cell Profile Comparable to That of Long-Term Non-Progressors
Cristina Cellerai, Alexandre Harari, Hans J. Stauss, Sabine Yerly, Anna María Geretti, Anne Carroll, T. T. Yee, Jonathan Ainsworth, Ian G. Williams, John F. Sweeney et al. · 2011 · PLoS ONE